Chondrocytes
Introduction
Growth of skeletal long bones occurs through the process of endochondral ossification. Endochondral bone formation is initiated with the condensation and chondrogenic differentiation of mesenchymal cells. Condensed mesenchymal cells are induced to undergo chondrogenesis by several regulatory pathways including those of transforming growth factor-b (TGF-b), parathyroid hormone relater peptide (PTHrP), hedgehog family proteins, as well as various other transcription factors. The Sox family of transcription factors regulates the formation of chondrogenic condensations and cartilage by controlling the expression of type II collagen and aggrecan, two cartilage specific markers (Bell et al., 1997; Lefebvre and de Crombrugghe, 1998; Sekiya et al., 2000) .
Endochondral bone growth is dependent upon the coordinated regulation of proliferation and differentiation of chondrocytes to form the cartilage template. Chondrocytes are found in a quiescent state in the resting zone of the growth plate where they are stimulated to proliferate. The proliferation of chondrocytes is maintained in part by both Indian Hedgehog (Ihh) cycles of proliferation, chondrocytes exit the cell cycle coincident with the reduction of the PTHrP gradient and begin to increase in cellular volume (hypertrophy), forming the prehypertrophic or maturation, region. The expansion of hypertrophic chondrocytes contributes significantly to the length of the developing bone. Hypertrophic chondrocytes are terminally differentiated and commence expression of type X collagen. Within the late hypertrophic region, the cartilage matrix undergoes both mineralization and vascularization. The mineralized cartilage matrix is replaced with bone matrix. The most mature hypertrophic chondrocytes undergo apoptosis, leaving behind a trabecular bone matrix.
Activating transcription factor-2 (ATF-2) is a member of the ATF/CREB (cAMP-response element binding protein) family of transcription factors, characterized by a basic region and a leucine zipper DNA-binding domain. This family of transcription factors binds cAMP-response elements (CREs) within target gene promoter regions in either homo or heterodimers. ATF-2 has been shown to regulate promoter activity of genes that are important for cartilage and bone growth. Data from our laboratory has shown that ATF-2 is essential for modulating the activity of the cell cycle-related genes cyclin D1 (Beier et al., 1999) and cyclin A (Beier et al., 2000) within growth plate chondrocytes. Gene expression of both cyclin A and cyclin D1 are targets of ATF-2 trans-activation, while loss of ATF-2 action in mutant ATF-2 chondrocytes leads to a decrease in gene expression. Addition of an exogenous ATF-2 expression plasmid restores promoter activity, further supporting the role of ATF-2 in regulating the expression of cyclins A and D1 in chondrocytes. The promoter regions of several other genes contain CRE motifs, but have yet to be examined for ATF-2 regulation. Additional genes, such as osteopontin, osteocalcin, alkaline phosphatase and the Rb family that contain CREs may also be controlled by ATF-2. Within the growth plate, ATF-2 is expressed in the resting and proliferating zones, yet is excluded from the hypertrophic region. The importance of ATF-2 in skeletal development was demonstrated with the production of ATF-2 deficient mice (Reimold et al., 1996) . ATF-2 deficient mice (ATF-2 m/m) express low amounts of a splice variant of ATF-2 that rescues $50% of transgenic animals from neonatal lethality. ATF-2 -deficient mice are smaller than wild type littermates at birth, and those that survive past weaning develop a hypochondroplasia-like dwarfism characterized by abnormal epiphysis and curvature of the spine. Chondrocyte proliferation is also reduced as determined by in vivo [ 3 H]-thymidine incorporation (Reimhold et al., 1996) . True ATF-2 null mice die at birth due to respiratory difficulties (Maekawa et al., 1999) .
The retinoblastoma protein family, or pocket proteins, is comprised of retinoblastoma (pRb) and pRb-related proteins, p107 and p130. These proteins regulate the G1-to S-phase transition by sequestering the E2F family (E2F1-E2F5) of transcription factors necessary for cell cycle progression (for review see Cobrinik, 2005) . pRb is found within resting (G0) cells in a hypophosphorylated state that allows for binding and sequestration of E2Fs. E2F proteins are released from pRb sequestration following phosphorylation by cyclin D-cyclin dependent kinase (cdk) 4 and 6 complexes in early G1 and cyclin E/cdk 2 complexes later in G1. After E2Fs are released, the cell enters S-phase and is committed to progress through the cell cycle. The dynamic relationship between the pocket proteins and E2Fs is essential in regulating cell proliferation and, in turn, differentiation. The pocket proteins differ with respect to their cellular expression patterns and in their interactions with E2Fs. pRb shows selective interactions with E2F1-3 while p107 and p130 bind more readily to E2F4-5 (for review see Cobrinik, 2005) .
Disruption of E2F-pocket protein dynamics inhibits normal skeletal bone growth by disrupting the endochondral ossification process. Chondrocytic differentiation of ATDC5 cells, a chondro-progenitor cell line (Atsumi et al., 1990) , is inhibited by ectopic expression of E2F1 as evidenced by inhibition of expression of the cartilage markers type II collagen, type X collagen and aggrecan (Scheijen et al., 2003) . Fibroblast growth factor (FGF) signaling inhibits longitudinal bone growth by specifically targeting p107 and p130 to induce chondrocyte cell cycle arrest. p107 and p130 have also been implicated in limb development (Cobrinik et al., 1996) and in the regulation of chondrocyte proliferation and differentiation . Our lab has shown that protein levels of pRb are reduced in ATF-2 m/m chondrocytes (Luvalle et al., 2003) suggesting that pRb expression is dependent on ATF-2 function. Basal pRb promoter activity is regulated through ATF-2 binding of the CRE motif (Zacksenhaus et al., 1993) . The promoter regions of p107 and p130 also contain CREs that may be targets of ATF-2 regulation. The phenotype of ATF-2 m/m mice may be the result of cumulative effects of various target genes including the pRb family.
Here we further investigate the abnormal development of ATF-2 deficient mice by examining the relationship between ATF-2 and pRb. We show that the normal spatial and temporal expression of each pocket protein within the growth plates of wild type animals and their altered expression in ATF-2 mutants. Expression of pRb mRNA is reduced in ATF-2 m/m chondrocytes compared to wild type due to the reduction of pRb promoter activity. We also show that that pRb expression is up-regulated in ATDC5 undergoing chondrogenic differentiation. ATF-2 deficient mice also exhibit reductions in collagen type X expression as compared to wild type counterparts. We also show that ATF-2 mutant mice display increases cellular proliferation as compared to their wild type littermates, both in vivo and in vitro. Taken together these data show that the loss of ATF-2 activity results in the decreased expression of pRb, and this decrease contributes to chondrocyte cell cycle deregulation and differentiation affecting hypertrophy, consequently resulting in appendicular dwarfism.
2.
Materials and methods
Mice and genotyping
Mice harboring either wild type or inactivated alleles of the ATF-2 gene were genotyped as previously described (Reimold et al., 1996) . Genomic DNA was isolated from the distal portion of the tail by standard phenol-chloroform extraction and genotype was determined by polymerase chain reaction (PCR).
2.2.
Cell culture ATDC5 chondrogenic cells were propagated in a 50:50 mixture of DMEM/F12 media supplemented with 5% fetal bovine serum, 100 lg/ml penicillin and 100 lg/ml streptomycin. For differentiation experiments, ATDC5cells at confluence were given complete media further supplemented with insulin-transferrin-selenium (ITS) reagent. Media was replaced every other day for the indicated time periods. Primary mouse chondrocytes were isolated from the ventral ribcage as previously described (Lefevbre et al., 1994) . Briefly, ventral ribcages were excised from neonate pups less than 2 days old. Tissues were digested in pronase, followed by digestion with collagenase D (3 mg/ml) in complete DMEM (DMEM + 10% FBS, 100 lg penicillin, 100 lg streptomycin). Cells were then grown in suspension over 1.5% agarose in phosphate buffered saline (PBS) coated plates for 3 days to ensure chondrogenic phenotype. Cell aggregates were digested in collagenase and plated in monolayer culture on sterile plastic dishes at 37°C in a 5% CO 2 atmosphere in complete DMEM.
Immunohistochemistry
Knee joints from newborn, 1 week and 3 week old mice were dissected and fixed in 4% paraformaldehyde in PBS (w/ v) for 24 h at 4°C. Tissues were processed though xylenes, dehydrated through graded alcohols and embedded in paraffin wax. Tissue sections were cut at 5 lm and attached to SuperFrost Plus (Fisher) microscope slides. For immunohistochemistry, slides were deparaffinized in Citrasolve (Fisher), and rehydrated through graded alcohols to distilled water. Microwave antigen retrieval was performed using antigen unmasking solution according to manufacturer's recommendations (Vector). The Vector Elite ABC Staining kit was used for immunohistochemical localization. Antibodies and working concentrations were as follows: rabbit anti-pRb (Delta bioLabs, 0.2 lg/ml); rabbit anti-p107 (Delta Biolabs, 0.2 lg/ml) rabbit anti-p130 (ABCam, 0.2 lg/ml); rabbit anti-Ki67 (ABCam, 0.1 lg/ml). As a negative control, normal rabbit IgG at the same concentration was used in place of primary antibody. Immunofluorescence for type X collagen was performed using a rabbit polyclonal antibody (gift from Danny Chan, Department of Biochemistry, The University of Hong Kong, Pokfulam, Hong Kong, China). Antigen unmasking was accomplished though incubation with 0.8% hylaranidase in PBS for 30 min prior to incubation with the primary antibody (1:2000). Alexa 488 (Molecular Probes, Invitrogen) goat antirabbit was used as a secondary antibody (1:1000). Omission of primary antibody served as a negative control. Immunofluorescence was visualized on a fluorescent microscope (DM IRBE; Leica) equipped with a digital camera. Intensity of immunofluorescence was measured using digital imaging software (IP Lab). Average intensities were determined from separate measurements of each growth plate of at least three individual animals. Bar graphs represent the mean of measured fluorescence intensity of at least three different animals at the indicated time points. Error bars represent the standard deviation of the mean.
RNA isolation and RT-PCR
RNA was extracted from confluent cells using the TriZol reagent according to manufacturer's suggestions. Reverse transcription of 2 lg of total cellular RNA was performed. Total cDNA was diluted 1:10 in sterile water, and 1 ll was used in subsequent PCR reactions. Quantitative real-time PCR for type X collagen mRNA expression was performed using the DyNAmo HS SYBR Green PCR kit (New England Biolabs) according to manufacturer's instructions. Real-time PCR analysis for pRb mRNA was performed using TaqMan Gene Expression Array combined with the TaqMan Universal PCR Master Mix (Applied Biosystems). PCR results were normalized to GAPDH PCR values. Primers used for SYBR green RT-PCR are as follows (target; forward, reverse): type X collagen; 5 0 -TG
Comparisons made between groups of SYBR green reactions were performed using the Pfaffl method (Pfaffl, 2001) , and the DDC t method for TaqMan Assay PCRs. The Pfaffl method takes into account different efficiencies of amplification between various primer sets in order to make accurate comparisons.
Transfections and luciferase assays
Primary chondrocytes were plated in a 24-well plastic culture plate at a cell density of 1.25 · 10 5 in DMEM media with 10% FBS without antibiotics for 24 h prior to transfection. Each well contained 0.2 lg of reporter plasmid DNA and 0.02 lg of pRLSV40 plasmid used for transfection normalization. Lipofectamine 2000 was used for transfections according to manufacturer's recommendations with few exceptions; briefly, plasmid DNA and 1 ll of transfection reagent were diluted separately in Opti-MEM serum free media. Diluted DNA and transfection reagent were combined to form complexes for 20 min prior to adding to cells. Cells were collected for luciferase activity 24 h after transfection. Luciferase assays were performed as previously described (Ma et al., 2007) . ATDC5 cells were transfected 24 h prior to collection as were those for primary cultures and collected at indicated time points for luciferase activity.
Cell cycle analysis
ATDC5 cells were collected at the indicated times following differentiation by adding hypotonic cell lysis buffer (0.5 g sodium citrate, 0.1% (v/v) Triton X-100) followed by removal of cells from the culture plate with a cell scraper. Propidium iodide solution was added to a final concentration of 30 lg/ ml with RNase A in order to stain DNA content. The cell suspension was then processed for flow cytometry in a FACS Calibur (BD BioSciences) flow cytometer. Cell cycle profiles were obtained using Cell Quest software. Analyses of cell cycle populations were performed using the ModFit Software package.
2.7.

BrdU incorporation
Primary chondrocytes from wild type and ATF-2 m/m newborn mice were isolated, differentiated over agarose and plated on plastic cell culture dishes at a cell density of 1.25 · 10 6 cells/ml. The following day, cells were pulse labeled with bromo-deoxyuridine (BrdU) to a final concentration of 10 lM in complete cell culture media for 4 h. The media was removed, cells were washed with PBS and supplemented with fresh media for 6 h prior to collection for cell cycle analysis. BrdU incorporation was detected by incubation with a FITC labeled BrdU antibody (BD Biosciences) according to the manufacturer's recommendations.
Results
Several studies have documented the functions of the pRb protein family in regulating chondrocyte cell cycle arrest and differentiation (Laplantine et al., 2002) . The effects of FGF signaling on chondrocyte cell cycle arrest are modulated through p107 and p130. Our laboratory, as noted earlier, has shown that loss of ATF-2 signaling leads to a reduction in pRb protein levels. Since ATF-2 expression is restricted to the resting and proliferative zones of the growth plate, we first sought to identify the spatial and temporal expression of the pRb family members within the growth plate in wild type and ATF-2 m/m animals at 0, 1 and 3 weeks of age. Expression of pRb was localized to the resting and proliferative region in newborn wild type proximal tibial sections (Fig. 1a) . In contrast, pRb expression was observed in the maturation and early hypertrophic regions in ATF-2 m/m proximal tibia (Fig. 1b) . Expression of p107 was not detected in wild type animals (Fig 1c) however, p107 staining was observed in tibial growth plate sections from newborn ATF-2 m/m animals (Fig. 1d) . Staining was localized to the late proliferative region. Expression of p130 was observed throughout the growth plate in both wild type and ATF-2 m/m tissues ( Fig.  1e and f) . ATF-2 m/m sections displayed more intense p130 staining as opposed to wild type tissue sections. By 1 week of age, pocket protein expression was increased and more uniform (Fig. 2) . pRb expression was localized to the late proliferative zone and pervaded throughout most of the hypertrophic region in wild type proximal tibia sections (Fig. 2a) . Expression of pRb was more restricted to the late proliferative and early hypertrophic regions of ATF-2 m/m growth plates (Fig. 2b) . There was some observed pRb immunostaining in the resting zones of both wild type and ATF-2 m/m sections ( Fig. 2a and b) . p107 expression was localized to the late proliferative and early hypertrophic zones in sections of wild type growth plate tissues (Fig. 2c) . p107 expression was observed in the late proliferative region, with sparse staining in the hypertrophic zone in ATF-2 m/m sections (Fig. 2d) . Staining for p130 expression was observed throughout the proliferative and hypertrophic zones in both wild type and ATF-2 m/m sections (Fig 2e and f) . At 3 weeks, pRb expression was detectable in wild type growth plates while expression in ATF-2 m/m tissues was diminished ( Fig. 3a and b) . Expression of p107 was reduced in wild type and ATF-2 m/m tissues at 3 weeks of age ( Fig. 3c and d) . p130 expression was observed predominantly in the proliferative region ( Fig. 3e and f) with some staining observed in resting zones ( Fig. 3e and f) .
We performed immunoblot experiments with protein from cultured primary chondrocytes to correlate the observed differences seen in immunohistochemical localization of the pRb protein family. Reduction of pRb protein expression has been demonstrated previously in ATF-2 m/m chondrocytes (pRb blot reprinted with permission LuValle et al., 2003) . Expression of p107 was up-regulated in response to ATF-2 deficiency. Expression of p130 was unchanged in ATF-2 m/m animals. Actin was used as a loading control (Fig. 4) .
ATF-2 recognizes CRE elements located in target gene promoters and subsequently alters gene expression. Given our results from immunohistochemistry and western blot experiments, we sought to determine the changes, if any, in mRNA expression in response to loss of ATF-2. Primary chondrocytes were isolated and cultured in vitro as described previously (Lefevbre et al., 1994) . Real-time PCR TaqMan Expression Assays were used to determine quantitative differences in pRb mRNA expression between wild type and ATF-2 m/m primary cells. Total RNA was isolated using the TriZol reagent, and cDNA was reverse transcribed in combination with an oligod(T) primer. ATF-2 m/m chondrocytes demonstrated a 40% reduction in pRb expression compared to cells isolated from wild type littermates (Fig. 5A) . Luciferase assays were used to examine the regulatory nature of ATF-2 in the pRb promoter region in order to correlate observed differences with the known function of ATF-2 as a transcription factor. Primary chondrocytes from wild type, heterozygous and ATF-2 m/m animals were cotransfected with plasmid DNA corresponding to a 1.3 kb fragment of the mouse pRb promoter cloned into the pGV-B luciferase reporter plasmid (Delehouzee et al., 2005) . A Renilla expression plasmid (pRLSV40) was used to normalize data for transfection efficiency. Wild type chondrocytes had the highest promoter activity, while ATF-2 m/m chondrocytes displayed an approximate 30% reduction in pRb promoter activity (Fig. 5B) .
In order to examine the role of pRb in chondrocyte development, we utilized the ATDC5 chondrogenic cell line to monitor pRb expression in response to differentiation. ATDC5 cells were grown to near confluence in DMEM/F12 (50:50) media with serum and antibiotics. Insulin-transferrin-selenium (ITS, Sigma) reagent was added after reaching confluence. Insulin at this concentration has been shown to induce differentiation of the cells to a more chondrocytic phenotype (Shukunami et al., 1996) . Cells were then collected at various time points for mRNA expression. pRb mRNA expression was quantified using the TaqMan Expression Array as described (Pfaffl, 2001 ) After the cells were differentiated for 8 days there was a 4-fold increase in pRb mRNA expression compared to cells at day 0. A further increase was seen in cells at day 11, and sustained levels were seen at day 14 (Fig. 6A, closed bars) . Expression of type X collagen was low from day 0 through day 4. After day 4, type X expression levels increased until day 14 when there was an observed 6-fold increase in mRNA expression from cells collected at day 0 (Fig.  6A, open bars) . pRb promoter activity in ATDC5 cells differentiated with ITS was coincident with observed expression changes over time (Fig. 6B) . After 8 days post-ITS treatment promoter activity increased 10-fold above the activity observed at the time of ITS treatment initiation (Fig. 6B , compare D0-D8). After day 8, promoter activity increased further and remained elevated through day 14. These data suggest that pRb expression was up-regulated in response to exogenous treatment of cells with insulin which induces chondrogenic differentiation of ATDC5 cells.
Cell cycle exit is a critical determinant in cellular differentiation. The role of pRb in regulating cell cycle progression has been well-established. pRb family members p107 and p130 mediate FGF induced cell cycle arrest in chondrocytes in response to FGF signaling (Laplantine et al., 2002) . Since the expression of pRb is up-regulated in ATDC5 cells undergoing differentiation, we sought to correlate pRb and type X collagen expression with cell cycle exit. ATDC5 cells were collected in hypotonic lysis buffer and stained with propidium iodide for flow cytometric analysis. Supplementing ATDC5 cell cul- Fig. 1 -Immunohistochemical localization of pocket proteins in newborn growth plates from wild type (+/+) and ATF-2 mutant (m/m) animals. Proximal tibial sections from newborn mice were fixed in 4% paraformaldehyde, embedded in paraffin and sectioned at 5 lm for immunohistochemistry. Primary antibodies against pRb (a and b), p107 (c and d) and p130 (e and f) were used as noted in Section 2. Control sections were incubated with non-specific IgG from the same host species as primary antibodies. Micrographs were taken at 20· magnification using a Leica DM2000 microscope equipped with a Leica DFC420C digital camera. Scale bar is 100 lm.
ture with insulin resulted in chondrogenic cell differentiation (Shukunami et al., 1996) . ATDC5 cells displayed a normal asynchronous cell cycle profile at the time of ITS supplementation (Day 0, Fig. 7) . After 24 h (Day 1) of ITS treatment, the number of cells in S-phase increased. Cell cycle profiles of cell cultures collected at subsequent time points showed a steady decrease in the number of cells in S-and G2/M-phases. The decrease in cellular growth was coincident with the increase in the number of cells in G1/G0, indicative of cell cycle exit. Depletion of pRb by RNAi in ATDC5 cells resulted in extensive apoptosis and cell death (data not shown).
Type X collagen is a marker of terminal differentiation in chondrocytes (Kielty et al., 1985; Reichenberger et al., 1991) . Type X collagen expression is restricted to the hypertrophic region within the growth plate. Immunofluorescence was used to examine the role that ATF-2 loss plays in chondrocyte differentiation. Tissues from 0, 1 and 3 week old wild type and ATF-2 m/m animals were fixed, processed, embedded in paraffin and further processed for immunofluorescence. Type X collagen expression was evident in the hypertrophic region in all tissues examined. Tibial growth plate sections from wild type and ATF-2 mutant animals Fig. 2 -Immunohistochemical localization of pocket proteins in 1 week old growth plates from wild type (+/+) and ATF-2 mutant (m/m) animals. Proximal tibial sections from 1 week old mice were fixed in 4% paraformaldehyde, embedded in paraffin and sectioned at 5 lm for immunohistochemistry. Primary antibodies against pRb (a and b), p107 (c and d) and p130 (e and f) were used as noted in Section 2. Control sections were incubated with non-specific IgG from the same host species as primary antibodies. Micrographs were taken at 20· magnification using a Leica DM2000 microscope equipped with a Leica DFC420C digital camera. Scale bar is 100 lm. displayed equal staining for type X collagen at 0 weeks of age ( Fig. 8A panels a and b) . Type X collagen staining was much more evident in wild type versus ATF-2 m/m animals at 1 week of age (Fig. 8A panels c and d) . Type X collagen staining in tibial growth plate section from 3 week old animals was more intense in wild type as compared to ATF-2 m/m animals ( Fig. 8A panels d and e) . The observed differences in type X collagen staining fluorescence intensity were measured in each growth plate in order to provide a quantitative comparison between groups. The fluorescence intensity corresponding to type X collagen was significantly different between wild type and mutant animals at 1 and 3 weeks of age ( Fig. 8B , P < 0.005). Growth plate sections from wild type animals demonstrated higher type X collagen expression than ATF-2 mutants at 1 week and 3 weeks of age. These data indicate that ATF-2 mutation does affect the expression of type X collagen reflecting a plausible role in the differentiation of chondrocytes. ATF-2 affects chondrocyte differentiation indirectly through regulation of the expression of one or multiple target genes. Fig. 3 -Immunohistochemical localization of pocket proteins in 3 week old growth plates from wild type (+/+) and ATF-2 mutant (m/m) animals. Proximal tibial sections from 3 week old mice were fixed in 4% paraformaldehyde, embedded in paraffin and sectioned at 5 lm for immunohistochemistry. Primary antibodies against pRb (a and b), p107 (c and d) and p130 (e and f) were used as noted in Section 2. Control sections were incubated with non-specific IgG from the same host species as primary antibodies. Micrographs were taken at 20· magnification using a Leica DM2000 microscope equipped with a Leica DFC420C digital camera. Scale bar is 100 lm.
The regulatory function of pRb in controlling the cell cycle occurs at the G1-to S-phase transition. The reduction of pRb expression observed in ATF-2 m/m animals could result in the loss of cell cycle control. We examined the proliferation of chondrocytes within the growth plate by immunostaining for the nuclear antigen Ki67, a well-known marker for proliferative cells. There was a clear increase in Ki67 staining in ATF-2 m/m animals compared to wild type at the 0 week time point (Fig. 9a and b) . Chondrocytes within the late proliferative and hypertrophic regions were negative for Ki67, indicative of cell cycle exit. Ki67 staining was more prevalent in wild type chondrocytes at 1 week of age than in ATF-2 m/m littermates ( Fig. 9c and d) . Finally, at 3 weeks of age, Ki67 staining was still observed in ATF-2 m/m tissues, while not detected in wild type tissues ( Fig. 9e and f) . These data indicate that chondrocyte proliferation is increased in ATF-2 mutant early neonates. The increase is proliferation is not continued through the later stages.
We also tested the cell cycle behavior of primary chondrocytes by BrdU labeling. Primary chondrocytes from wild type and ATF-2 mutant animals were labeled with BrdU to determine the population of cells actively undergoing DNA synthesis. We determined differences in G1-to S-phase transition between wild type and ATF-2 m/m chondrocytes, a checkpoint specifically controlled by pRb. An increased number of cells had undergone DNA synthesis and incorporated BrdU in ATF-2 m/m chondrocytes as compared to wild type (Fig.  10) . The percentage of cells within the S-phase fraction of the cell cycle was increased in ATF-2 m/m cells. Theses results, taken together with the immunostaining for Ki67, indicate that ATF-2 loss results in aberrant cell cycle control mainly at the G1-to S-transition.
Discussion
Endochondral ossification is dependent on the coordinated regulation of chondrocyte proliferation and differentiation. Previous results from our lab have demonstrated that ATF-2 acts as a global regulator of chondrocyte proliferation through regulation of the cyclin D1 (Beier et al., 1999) and cyclin A (Beier et al., 2000) promoters. We have, more recently, implicated ATF-2 in controlling apoptosis of hypertrophic chondrocytes via regulation of the bcl-2 promoter (Ma et al., 2007) . Other potential target genes of ATF-2 include the pocket proteins pRb, p107 and p130. The necessary regulation of cell cycle exit and terminal differentiation of chondrocytes renders the pocket proteins ideal candidates for ATF-2 regulation. Pocket protein function involves regulation of cell cycle progression, therefore centrally modulating cellular proliferation and differentiation processes. Regulation of pocket protein expression is a plausible mechanism for ATF-2 function in chondrocytes. was reversed transcribed using superscript II reverse transcriptase with an oligo-d(T) primer. Real-time PCR was performed using TaqMan Gene Expression Array kit for mouse pRb on an ABI7000 machine. Values were normalized to b-actin mRNA levels and represent means from three different animals run in triplicate. Comparisons between groups were made using the DDC t method. (B) pRb promoter activity in primary chondrocytes. A 1.3 kb portion of the pRb promoter preceding a luciferase reporter construct was transfected into primary chondrocytes isolated from wild type (+/+), heterozygous (+/m) and ATF-2 mutant (m/m) animals. Bar graphs represent the mean normalized luciferase activity of triplicate samples from three different animals for each genotype. Error bars represent SEM. pRb promoter activity in ATF-2 mutant (m/ m) chondrocytes is roughly 30% decreased as compared to activity in wild type (+/+) chondrocytes.
Loss of ATF-2 alters the expression of pRb in chondrocytes. Previous data from our laboratory have shown that pRb protein levels were decreased in primary chondrocytes from ATF-2 mutant animals (LuValle et al., 2003) . Spatially, pRb is expressed in the resting and early proliferative region of the growth plate. However, ATF-2 deficient mice express pRb in the maturation and hypertrophic regions. pRb may function within the resting and early proliferative regions by regulating cell cycle entry. Loss of ATF-2, leading to reduced pRb levels in this region could lead to cell cycle Fig. 6 -pRb mRNA expression is increased coincident with chondrogenic differentiation. (A) ATDC5 cells were treated with insulin-transferrin-selenium reagent (ITS) to induce chondrogenic differentiation. Total RNA was extracted at various timepoints (day 0, D0; day 1, D1; day 4, D4; day 8, D8; day 11, D11; day 14, D14) after treatment initiation. Total RNA was extracted and reverse transcribed as previously described. Real-time PCR for pRb was performed as previously described. Real-time PCR for type X collagen was performed using Dynamo DS Sybr green qPCR kit (New England Biolabs) with primers for type X collagen and normalized to b-actin. Type X collagen mRNA expression comparisons were determined using the Pfaffl method (Pfaffl, 2001) , accounting for unequal PCR efficiencies between primer sets. RT-PCR was performed in triplicate on cDNA from at least three different animals. (B) pRb promoter activity in differentiated ATDC5 cells. Differentiated ATDC5 cells were transfected 24 h prior to collection with the pRb promoter-luciferase construct. Cell were collected and assayed for luciferase activity on days indicated (D0, day 0 = initiation of ITS treatment). Luciferase activity was normalized to Renilla luciferase activity for transfection efficiency. Bar graphs represent the mean normalized luciferase activity of triplicate samples from three independent experiments. Error bars represent SEM. pRb promoter activity is increased as differentiation progresses, mirroring the observed increased expression of pRb mRNA.
entry. The altered, more downstream spatial expression of pRb in ATF-2 m/m animals may be indicative of the important role pRb plays in regulating cell cycle exit and ultimately chondrocyte differentiation. It also suggests that the ATF-2 m/m phenotype results from not only the reduced number of proliferative cells (Reimold et al., 1996) but also a possible disruption in the normal differentiation program, specifically control of cell cycle exit. pRb plays a central role in cell cycle regulation, but also functions in terminal differentiation of numerous cell types (Cobrinik et al., 1996; Zacksenhaus et al., 1996; Walsh and Perlman, 1997; Thomas et al., 2001; Fajas et al., 2002) .
ATF-2 may control the normal differentiation of chondrocytes indirectly, by influencing the expression of pRb. Fig. 7 -Cell cycle analysis of ATDC5 cells undergoing chondrogenic differentiation. ATDC5 cells were cultured and treated with ITS reagent to stimulate chondrogenic differentiation. At indicated timepoints, cells were collected in hypotonic lysis buffer with propidium iodide and processed for flow cytometry. DNA content was measured to determine the cell cycle profile. At least 30,000 cell nuclei were analyzed for each collected time point. Cell cycle profiles were analyzed using the ModFit software package. Accumulation of cells in G1/G0 occurs over time is indicative of cell cycle exit. At the time of ITS initiation (D0), 62% of cells were found in G1/G0. After 24 h of ITS treatment, 42% of cells were in G1/G0. The number of cells in G1 then increases over time to a maximum of 94% at D11. The subG1 peak represents the subpopulation of cells undergoing apoptosis.
There is an increase in pRb expression in the ATF-2 m/m growth plate that does not correlate with results from immunoblotting experiments (Figs. 1-3 compared to Fig.   4 ). However, chondrocytes within the resting zone in wild type growth plates express higher levels of pRb than those of ATF-2 m/m chondrocytes. This difference could account plates from wild type and ATF-2 m/m animals were dissected, processed and sectioned for immunohistochemistry as previously described. Tibial growth plates from newborn (a and b), 1 week (c and d) and 3 week (e and f) old mice were used. Staining was restricted, as expected, to the hypertrophic region. (B) Intensity of fluorescence from immunostaining was measured using IP Lab digital imaging software. Mean intensity per unit area was measured from at least three different animals per time point and genotype. Statistical comparisons were made using Student's t-test. Bars represent mean intensities ± the standard deviation of the respective mean. Asterisk ( * ) indicates significant difference (P < 0.05) between wild type and mutant growth plates at the specific age.
for the discrepancy between in vitro (immunoblot) and in vivo (immunohistochemistry) results where pRb expression is reduced in primary ATF-2 mutant chondrocytes. This phenomenon is not mirrored in vivo by ATF-2 mutant chondrocytes where pRb expression is not dramatically reduced. The most striking result may be the spatial change in pRb expression. pRb is expressed in the resting zone and in the late proliferative zone in wild type chondrocytes, but in ATF-2 m/m chondrocytes pRb expression is observed in the maturation zone at higher levels than in wild type, as well as throughout the hypertrophic region. There is also a clear reduction in the number of cells expressing pRb in the resting zone. The reduction of pRb in the resting zone may contribute to the increase in proliferative cells in ATF-2 mutant animals. Decreased pRb expression may be the result of suboptimal activation of the pRb promoter following loss of ATF-2 activation. Results from promoter studies (Fig. 5B ) support this finding. Likewise, ATF-2 has been shown to be necessary for optimal pRb promoter activity (Zacksenhaus et al., 1993) . The alteration of pRb expression may allow cells to enter and exit the cell cycle at earlier points, leading to premature growth plate closure and culminating in the observed dwarfed phenotype. Increased Ki67 immunostaining in ATF-2 m/m growth plates combined with the increase in BrdU incorporation in primary chondrocytes from ATF-2 m/m animals indicate a loss of cell cycle control.
Other members of the pocket protein family, p107 and p130 are potential targets of ATF-2 regulation. Interestingly, p107 protein levels were increased in ATF-2 mutant chondrocytes while p130 remained stable. The increase in p107 levels may reflect a response to diminished levels of pRb and a compensatory mechanism whereby the increased p107 levels could interact and sequester E2F transcription factors necessary for cell cycle progression. Our immunohistochemical data replicate this phenomenon, demonstrating that spatial expression of p107 in the ATF-2 m/m growth plate is localized to the maturation region. The increase in p107 is another possible contributing factor to the dwarfed phenotype of ATF-2 m/m animals. This increase, combined with steady levels of p130 observed in ATF-2 m/m animals, may result in a shorter period of chondrocyte proliferation, resulting in premature cell cycle exit and growth retardation.
Chondrocyte growth arrest has been largely associated with p107 and p130 (Laplantine et al., 2002; Rossi et al., 2002) , with little mention regarding pRb. We were able to examine pRb expression in differentiating cells by using the ATDC5 chondrogenic cell line. We show here that pRb expression is tightly correlated with expression of type X Fig. 9 -Ki67 immunostaining in wild type (+/+) and ATF-2 mutant (m/m) animals. Growth plates from wild type and ATF-2 m/ m animals were dissected, processed and sectioned for immunohistochemistry as previously described. Tibial growth plates from newborn (a and b), 1 week (c and d) and 3 week (e and f) old mice were used. Hematoxylin was used as a counterstain. Ki67 staining was observed within chondrocytes actively undergoing cell cycle progression.
collagen, a marker for chondrocyte differentiation. Furthermore, ATDC5 cells treated with insulin have been shown to produce increased amounts of proteoglycans, another chondrocyte differentiation marker (Phornphutkul et al., 2006) . ATDC5 cells express type X collagen and pRb at higher levels following prolonged insulin treatment. These data imply that pRb plays a definitive role in chondrocyte differentiation in vitro.
Cell cycle exit is a hallmark of terminal differentiation. The accumulation of cells in G1/G0 of the cell cycle is a sufficient indication of cell cycle exit. As the number of cells in G1/ G0 increase, there is a decrease in the number of cells in Sand G2/M-phases of the cell cycle. Differentiation of ATDC5 cells stimulates expression of pRb and type X collagen while simultaneously yielding an increase of cells exiting the cell cycle. These results suggest that pRb not only regulates cell cycle exit, but also plays a role in determining the normal chondrocyte differentiation.
The temporal pattern of pRb expression in the distinct regions of the growth plate directly affects growth plate development. The altered spatial/temporal expression of pRb in response to loss of ATF-2 signaling could induce cells to exit the cell cycle prematurely. Exit from the cell cycle would likely trigger advanced terminal differentiation, ultimately leading to closure of the growth plate and a dwarfed phenotype. The reduced expression of pRb in ATF-2 mutant cells lead to delayed differentiation. The combination of reduced proliferation, delayed differentiation and increased apoptosis in later stage hypertrophic chondrocytes is likely to contribute additively to the observed dwarfed phenotype of the ATF-2 m/m mice.
The unique ability of endochondral cartilage to undergo maturation prior to hypertrophy may delineate the role of pRb in bone development. Expression of pRb throughout the maturation region suggests a plausible role of pRb in this region. Cartilage specific deletion of pRb would best demonstrate the role of pRb in the endochondral process aside from fetal limb development (Cobrinik et al., 1996) . Our lab is currently undertaking these projects to better understand the function of pRb in the growth plate. Fig. 10 -Incorporation of BrdU in wild type (+/+) and ATF-2 mutant (m/m) primary chondrocytes. Primary chondrocytes from wild type and ATF-2 mutant animals were isolated and plated in plastic cell culture plates. Cells were labeled with 10 lM BrdU for 4 h in complete DMEM media. BrdU containing media was then removed, followed by washing with PBS and replacement with fresh media. Cells were allowed to recuperate for 6 h before being collected and processed for flow cytometric analysis of cell cycle status, and BrdU incorporation. The number of BrdU positive cells was increased in ATF-2 m/m chondrocytes. Cell cycle analysis of the fraction of cells that were BrdU positive shows an increase in the S-phase fraction.
